Gastrooesophageal Cancer research hub

Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer

This study looks at a new drug, trastuzumab deruxtecan, for people with stomach or food pipe cancer that has a specific marker (HER2 positive) and has tiny traces of cancer DNA in their blood after surgery and chemotherapy. It aims to prevent the cancer from coming back.